Glucose metabolism disorders and hypoglycemic therapy in patients hospitalized for elective lower limb arthroplasty: a prospective, single-center, real-world study

Cover Page

Cite item

Full Text

Abstract

Aim. To assess the incidence of glucose metabolism disorders, administered hypoglycemic therapy and its effectiveness in a cohort of patients with previously diagnosed diabetes mellitus (DM) hospitalized for scheduled lower limb joint arthroplasty.

Materials and methods. The study included 502 patients. Medical history, information about previously diagnosed DM and prescribed hypoglycemic therapy were collected in all patients according to medical documentation, as well as according to the patients’ survey. Within the preoperative examination, the glucose level was measured, and in patients with previously diagnosed diabetes, measuremaent of the HbA1c level was recommended.

Results. The study population included 180 (35.9%) males and 322 females (64.1%). Among them, 99 (19.7%) patients had disorders of glucose metabolism [type 1 diabetes – 1 (0.2%) patient, type 2 diabetes – 90 (17.9%) patients, impaired glucose tolerance (IGT) – 8 (1.6%) patients]. In 8 patients, type 2 diabetes was newly diagnosed during the preoperative examination. HbA1c was measured before hospitalization in 26 patients with diabetes, the mean level was 7.0±1.4%. Regarding the analysis of hypoglycemic therapy, almost half of the patients with DM – 47 (47.5%) – received metformin monotherapy, 8 patients with IGT and 8 patients with newly diagnosed DM did not receive any drug therapy. Target glycemic levels during therapy were achieved in 36 (36.4%) patients, and target HbA1c levels were achieved in 21 patients.

Conclusion. The cohort of patients hospitalized for elective lower limb joint arthroplasty is characterized by a relatively high incidence of glucose metabolism disorders, and in some patients, DM was newly diagnosed during the preoperative examination. Metformin is most often used as hypoglycemic therapy, and the target values of glycemia during treatment were achieved in less than half of the patients. The monitoring of the level of glycated hemoglobin is low and requires additional population analysis in order to determine the causes and optimize the strategy of patient management.

About the authors

Elena A. Okisheva

Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: e.okisheva@gmail.com
ORCID iD: 0000-0003-2977-7203

канд. мед. наук, доц. каф. факультетской терапии №1 Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Olga Yu. Trushina

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-5820-1759

д-р мед. наук, проф. каф. факультетской терапии №1 Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Milana M. Mamaeva

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0009-0004-0811-8756

студентка Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Elena A. Redyanova

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0009-0004-5567-5299

студентка Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Anna A. Zhazhieva

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0009-0009-1010-5483

студентка Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Irina D. Chasova

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0009-0003-8385-0341

студентка Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Alexander S. Panferov

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-4324-7615

канд. мед. наук, доц. каф. факультетской терапии №1 Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Maxim M. Bogdanov

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0001-8603-2510

врач травматолог-ортопед Клиники травматологии, ортопедии и патологии суставов

Russian Federation, Moscow

Alexey V. Lychagin

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-2202-8149

д-р мед. наук, проф., зав. каф. травматологии, ортопедии и хирургии катастроф Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Victor V. Fomin

Sechenov First Moscow State Medical University (Sechenov University)

Email: e.okisheva@gmail.com
ORCID iD: 0000-0002-2682-4417

чл.-кор. РАН, д-р мед. наук, проф., проректор по инновационной и клинической деятельности, зав. каф. факультетской терапии №1 Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

References

  1. Середа А.П., Кочиш А.А., Черный А.А., и др. Эпидемиология эндопротезирования тазобедренного и коленного суставов и перипротезной инфекции в Российской Федерации. Травматология и ортопедия России. 2021;27(3):84-93 [Sereda AP, Kochish AA, Cherny AA, et al. Epidemiology of Hip And Knee Arthroplasty and Periprosthetic Joint Infection in Russian Federation. Traumatology and Orthopedics of Russia. 2021;27(3):84-93 (in Russian)]. doi: 10.21823/2311-2905-2021-27-3-84-93
  2. Алексеева Л.И., Таскина Е.А., Кашеварова Н.Г. Остеоартрит: эпидемиология, классификация, факторы риска и прогрессирования, клиника, диагностика, лечение. Современная ревматология. 2019;13(2):9-21 [Alekseeva LI, Taskina EA, Kashevarova NG. Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment. Modern Rheumatology Journal. 2019;13(2):9-21 (in Russian)]. doi: 10.14412/1996-7012-2019-2-9-21
  3. Espindola R, Vella V, Benito N, et al. Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study. Clin Microbiol Infect. 2022;28(10):1359-66. doi: 10.1016/j.cmi.2022.05.010
  4. Божкова С.А., Тихилов Р.М., Андрияшкин В.В., и др. Профилактика, диагностика и лечение тромбоэмболических осложнений в травматологии и ортопедии: методические рекомендации. Травматология и ортопедия России. 2022;28(3):136-66 [Bozhkova SA, Tikhilov RM, Andriyashkin VV, et al. Prevention, Diagnosis and Treatment of Thromboembolic Complications in Traumatology and Orthopedics: Methodological Guidelines. Traumatology and Orthopedics of Russia. 2022;28(3):136-66 (in Russian)]. doi: 10.17816/2311-2905-1993
  5. Заболотских И.Б., Малышев Ю.П., Дунц П.В., и др. Периоперационное ведение взрослых пациентов с сопутствующим сахарным диабетом: методические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов» (второй пересмотр). Вестник интенсивной терапии им. А.И. Салтанова. 2023;1:14-33 [Zabolotskikh IB, Malyshev YuP, Dunts PV, et al. Perioperative management of adult patients with concomitant diabetes mellitus: guidelines of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists” (second revision). Annals of Critical Care. 2023;1:14-33 (in Russian)]. doi: 10.21320/1818-474X-2023-1-14-33
  6. Zhang X, Hou A, Cao J, et al. Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review. Front Endocrinol (Lausanne). 2022;13:841256. doi: 10.3389/fendo.2022.841256
  7. Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Сахарный диабет 2 типа у взрослых. Сахарный диабет. 2020;23(2S):4-102 [Dedov II, Shestakova MV, Mayorov AY, et al. Diabetes mellitus type 2 in adults. Diabetes Mellitus. 2020;23(2S):4-102 (in Russian)]. doi: 10.14341/DM12507
  8. Gortler H, Rusyn J, Godbout C, et al. Diabetes and Healing Outcomes in Lower Extremity Fractures: A Systematic Review. Injury. 2018;49:177-83. doi: 10.1016/j.injury.2017.11.006
  9. Fernandes GS, Valdes AM. Cardiovascular disease and osteoarthritis: common pathways and patient outcomes. Eur J Clin Invest. 2015;45(4):405-14. doi: 10.1111/eci.12413
  10. Tsai HJ, Hsu YH, Huang YW, et al. Use of non-steroidal anti-inflammatory drugs and risk of chronic kidney disease in people with Type 2 diabetes mellitus, a nationwide longitudinal cohort study. Diabet Med. 2015;32(3):382-90. doi: 10.1111/dme.12610
  11. Reynolds CA, Minic Z. Chronic Pain-Associated Cardiovascular Disease: The Role of Sympathetic Nerve Activity. Int J Mol Sci. 2023;24(6):5378. doi: 10.3390/ijms24065378
  12. Holt A, Strange JE, Nouhravesh N, et al. Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2023;81(15):1459-70. doi: 10.1016/j.jacc.2023.02.027
  13. Bolognesi MP, Marchant MH Jr, Viens NA, et al. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty. 2008;23(6 Suppl. 1):92-8. doi: 10.1016/j.arth.2008.05.012
  14. Mills JL, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk Stratification Based on Wound, Ischemia, and Foot Infection (WIfI). J Vasc Surg. 2014;59:220-34.e1-2. doi: 10.1016/j.jvs.2013.08.003
  15. Lenguerrand E, Whitehouse MR, Beswick AD, et al. Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study. Lancet Infect Dis. 2018;18(9):1004-14. doi: 10.1016/S1473-3099(18)30345-1
  16. Bardia A, Khabbaz K, Mueller A, et al. The Association Between Preoperative Hemoglobin A1C and Postoperative Glycemic Variability on 30-Day Major Adverse Outcomes Following Isolated Cardiac Valvular Surgery. Anesth Analg. 2017;124(1):16-22. doi: 10.1213/ANE.0000000000001715
  17. van den Boom W, Schroeder RA, Manning MW, et al. Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries. Diabetes Care. 2018;41(4):782-8. doi: 10.2337/dc17-2232
  18. Godshaw BM, Ojard CA, Adams TM, et al. Preoperative Glycemic Control Predicts Perioperative Serum Glucose Levels in Patients Undergoing Total Joint Arthroplasty. J Arthroplasty. 2018;33(7S):S76-80. doi: 10.1016/j.arth.2018.02.071

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The prevalence of glucose metabolism disorders in the study population

Download (57KB)
3. Fig. 2. The fasting blood glucose levels in patients with normoglycemia (left), and in patients with impaired carbohydrate metabolism (right)

Download (82KB)

Copyright (c) 2024 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies